Recently, Pune has witnessed an alarming rise in cases of Guillain-Barr Syndrome (GBS), a rare but serious neurological disorder. While GBS cases are sporadic worldwide, this sudden outbreak in ...
Pune: A 16-year-old tabla player from Jalna, who was the first reported Guillain-Barré Syndrome (GBS) case in Pune's ...
The initiative intends to track and prevent the spread of communicable, vector-borne, and water-borne diseases across the ...
Pune: The city reported only one case of possible Guillain-Barré Syndrome on Monday, in a patient who was brought to Pune for treatment from another district. Officials said the surge that began ...
The Guillain-Barre Syndrome (GBS) outbreak in Pune has subsided considerably, health officials said on Wednesday, adding that there were no new hospital admissions linked to the rare neurological ...
Pune district reported an unusual spike in GBS cases since January 9, 2025, with cases being reported in clusters from areas such as Nande Gaon, Nanded, Dhayari, Kirkitwadi and Khadakwasla, among othe ...
The Guillain-Barré Syndrome (GBS) outbreak in Pune has shown a significant decline, bringing relief to residents and health authorities. The Pune Municipal Corporation (PMC) has reported no new ...
Officials said the district saw an unusual surge in cases from January 9, particularly in Nande Gaon, Nanded, Dhayari, Kirkitwadi, and Khadakwasla. Of the 141 reported cases, 120 have been confirmed ...
Pune Rural, and other districts. Health officials are closely monitoring the situation and have urged medical facilities to remain vigilant. Advt The Guillain-Barre Syndrome is a rare neurological ...
The fatality count due to suspected Guillain-Barre Syndrome (GBS) rose to 11 after two more patients died in Pune hospitals during treatment, officials said on Wednesday. Amid the surge in ...
Pune: The city on Sunday had zero new cases of Guillain-Barré Syndrome, health department data showed. There were no casualties either, with the death toll holding at 11. The last casualties were ...
Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.